Enteral Access Technologies

Enteral Access Technologies is a private UK medical device company developing and manufacturing products for safer placement of nasogastric and orogastric feeding and decompression tubes. Its lead and apparently primary commercial product, DoubleCHEK, combines carbon dioxide and pH indication in a bedside device intended to help clinicians detect airway misplacement and confirm gastric placement without relying as heavily on confirmatory X-rays. The company markets DoubleCHEK as a lower-cost, simple-to-use solution compatible with existing tube-placement workflows, and states that the product has UKCA marking and use within the NHS. Enteral Access Technologies appears focused on patient safety in enteral access rather than therapeutics, with commercialization activity in the UK and expansion efforts into the United States and Europe.